Microbot Medical Reports Leadership & Compensation Changes
Ticker: MBOT · Form: 8-K · Filed: Feb 27, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, compensatory-arrangements
TL;DR
**Microbot Medical filed an 8-K about leadership changes and officer compensation, but the specific details aren't in this snippet.**
AI Summary
Microbot Medical Inc. filed an 8-K on February 27, 2024, reporting events that occurred on February 22, 2024. The filing indicates changes in leadership, specifically the departure, election, or appointment of certain officers and directors, along with compensatory arrangements for officers. However, the specific individuals or financial details of these changes are not provided in this excerpt.
Why It Matters
Changes in executive leadership and compensation structures can signal strategic shifts or operational adjustments, potentially impacting the company's future direction and investor confidence.
Risk Assessment
Risk Level: medium — The filing indicates changes in key personnel and their compensation, which can introduce uncertainty or signal significant strategic shifts for the company.
Key Players & Entities
- Microbot Medical Inc. (company) — registrant
- STEMCELLS INC (company) — former company name
- CYTOTHERAPEUTICS INC/DE (company) — former company name
FAQ
What company filed this 8-K?
Microbot Medical Inc.
What was the earliest event date reported in this 8-K?
February 22, 2024.
What items were reported in this 8-K filing?
Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits).
When was this 8-K filed with the SEC?
February 27, 2024.
What is the state of incorporation for Microbot Medical Inc.?
Delaware.
Filing Stats: 443 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2024-02-26 18:42:53
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-007874.txt ( ) — 206KB
- mbot-20240222.xsd (EX-101.SCH) — 3KB
- mbot-20240222_lab.xml (EX-101.LAB) — 33KB
- mbot-20240222_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: February 26, 2024